Related references
Note: Only part of the references are listed.CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/-catenin signaling pathway
Zhaowei Chu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Downregulated expression of CFHL1 is associated with unfavorable prognosis in postoperative patients with hepatocellular carcinoma
Hao Feng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells
Qin Zhang et al.
EBIOMEDICINE (2019)
Functional role of SGK3 in PI3K/Pten driven liver tumor development
Hui Cao et al.
BMC CANCER (2019)
High serum interleukin-34 level is a predictor of poor prognosis in patients with non-viral hepatocellular carcinoma
Yu Noda et al.
HEPATOLOGY RESEARCH (2019)
Anti-tumor effect of LATS2 on liver cancer death: Role of DRP1-mediated mitochondrial division and the Wnt/β-catenin pathway
Lijuan Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1
Junsheng Gu et al.
CANCER CELL INTERNATIONAL (2019)
Cell adhesion is regulated by CDK1 during the cell cycle
Matthew C. Jones et al.
JOURNAL OF CELL BIOLOGY (2018)
Metformin induces miR-378 to downregulate the CDK1, leading to suppression of cell proliferation hepatocellular in carcinoma
Jin Zhou et al.
ONCOTARGETS AND THERAPY (2018)
Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients
Liping Zhuang et al.
BIOMED RESEARCH INTERNATIONAL (2018)
CDC20 regulates cardiac hypertrophy via targeting LC3-dependent autophagy
Yun-Peng Xie et al.
THERANOSTICS (2018)
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1
Qin Shi et al.
CANCER BIOMARKERS (2017)
MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1
Yuanhang Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer
Xin Fu et al.
ONCOTARGETS AND THERAPY (2016)
shRNA-mediated silencing of the RFC3 gene suppresses hepatocellular carcinoma cell proliferation
Zhicheng Yao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Precore/Core Region Mutations in Hepatitis B Virus DNA Predict Postoperative Survival in Hepatocellular Carcinoma
Ying Xie et al.
PLOS ONE (2015)
The expression of CDK1 is associated with proliferation and can be a prognostic factor in epithelial ovarian cancer
Qinghua Xi et al.
TUMOR BIOLOGY (2015)
miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3
Yi Zhang et al.
TUMOR BIOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Minichromosome Maintenance (MCM) Family as potential diagnostic and prognostic tumor markers for human gliomas
Cong Hua et al.
BMC CANCER (2014)
High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients
Wen-Wei Sung et al.
BMC CANCER (2014)
Cyclin B1/Cdk1 Coordinates Mitochondrial Respiration for Cell-Cycle G2/M Progression
Zhaoqing Wang et al.
DEVELOPMENTAL CELL (2014)
CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
Wen-jing Wu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Association Study of Germline Variants in CCNB1 and CDK1 with Breast Cancer Susceptibility, Progression, and Survival among Chinese Han Women
Yan Li et al.
PLOS ONE (2013)
Individualized hepatocellular carcinoma risk: The challenges for designing successful chemoprevention strategies
Cristina Della Corte et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Why Your New Cancer Biomarker May Never Work: Recurrent Patterns and Remarkable Diversity in Biomarker Failures
Scott E. Kern
CANCER RESEARCH (2012)
High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
Bjorn Nodin et al.
DIAGNOSTIC PATHOLOGY (2012)
A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
Stephanie Roessler et al.
CANCER RESEARCH (2010)
Hepatocellular carcinoma: a global view
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma
Elisa Wurmbach et al.
HEPATOLOGY (2007)
The challenges of gene expression microarrays for the study of human cancer
Anna V. Tinker et al.
CANCER CELL (2006)
MCM proteins and DNA replication
D Maiorano et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
Gene expression patterns in human liver cancers
X Chen et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Rfc4 interacts with Rpa1 and is required for both DNA replication and DNA damage checkpoints in Saccharomyces cerevisiae
HS Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
